WuXi Biologics increases issued shares through option exercise

WuXi Biologics (Cayman) Inc. (HKEX:2269) reported a change in its issued share capital on April 9, 2025, according to a Next Day Disclosure Return. The company issued 207,000 new ordinary shares following the exercise of share options under the Pre-IPO Share Option Scheme adopted on January 5, 2016. The shares were issued at HKD 1.56 per share. This increases the total number of issued shares to 4,108,305,791. The company also reported that 17,050,000 shares were repurchased on the Exchange at prices ranging from HKD 16.82 to HKD 18.82, for a total consideration of HKD 298,611,160. These shares are intended for cancellation.